Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Healthy You
    • Job listings
    • Q&As
    • Special sections
  • Multimedia
    • Quiz
    • Podcasts
    • Videos
    • App
  • FAQs
    • Advertising
    • Subscriptions
    • For APHA members
    • Internships
    • Change of address
  • About
    • About The Nation's Health
    • Submissions
    • Permissions
    • Purchase articles
    • Join APHA
  • Contact us
    • Feedback
  • APHA
    • AJPH
    • NPHW

User menu

  • My alerts

Search

  • Advanced search
The Nation's Health
  • APHA
    • AJPH
    • NPHW
  • My alerts
The Nation's Health

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Healthy You
    • Job listings
    • Q&As
    • Special sections
  • Multimedia
    • Quiz
    • Podcasts
    • Videos
    • App
  • FAQs
    • Advertising
    • Subscriptions
    • For APHA members
    • Internships
    • Change of address
  • About
    • About The Nation's Health
    • Submissions
    • Permissions
    • Purchase articles
    • Join APHA
  • Contact us
    • Feedback
  • Follow The Nation's Health on Twitter
  • Follow APHA on Twitter
  • Visit APHA on Facebook
  • Follow APHA on Youtube
  • Follow APHA on Instagram
  • Follow The Nation's Health RSS feeds
NewsGlobe

Malaria vaccine candidate shows promising early results, study finds

Aaron Warnick
The Nation's Health July 2021, 51 (5) 16;
Aaron Warnick
  • Search for this author on this site
Figure

Malaria spread by mosquitoes kills as many as 1 million people around the world each year.

Photo courtesy CDC PHIL

In the midst of a global campaign to vaccinate the world against COVID-19, researchers reported success with a vaccine to combat a longtime global killer — malaria.

April study results from a Phase IIB trial of a malaria vaccine candidate showed 77% efficacy, researchers from the Oxford Martin Program on Vaccines reported in The Lancet. The vaccine is the first candidate to reach a target effectiveness set by the World Health Organization.

“A highly effective malaria vaccine would mark a major turning point in the global campaign to end humanity’s oldest, deadliest disease,” Malaria No More CEO Martin Edlund told The Nation’s Health.

Each year, as many as 1 million people die from malaria, with most deaths among children under age 5, according to UNICEF. Almost 300 million people annually suffer from acute malaria. Most cases occur in sub-Saharan Africa, where the disease is a leading cause of death for young children.

“We are just not making the progress we need for elimination,” said Regina Rabinovich, MD, MPH, director of the Malaria Elimination Initiative at the Barcelona Institute for Global Health.

Non-vaccine interventions, such as mosquito elimination and bed nets, have reduced some malaria illness and death. According to the World Health Organization’s “2020 World Malaria Report,” more than 1.5 billion malaria cases and 7.6 million deaths were averted in the previous two decades. But with climate change expected to further the range of malaria-carrying mosquitoes, finding a successful vaccine is crucial.

“The COVID-19 pandemic and the rapid deployment of vaccines has taught us that we can have good science and we can have urgency, and that urgency should be driving us now,” she told The Nation’s Health.

For more information on malaria, visit www.cdc.gov/malaria.

  • Copyright The Nation’s Health, American Public Health Association
PreviousNext
Back to top

In this issue

The Nation's Health: 51 (5)
The Nation's Health
Vol. 51, Issue 5
July 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)

Healthy You

Print
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article
We do not capture any email addresses.
Enter multiple addresses on separate lines or separate them with commas.
Malaria vaccine candidate shows promising early results, study finds
(Your Name) has sent you a message from The Nation's Health
(Your Name) thought you would like to see this item on The Nation's Health website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Malaria vaccine candidate shows promising early results, study finds
Aaron Warnick
The Nation's Health July 2021, 51 (5) 16;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Malaria vaccine candidate shows promising early results, study finds
Aaron Warnick
The Nation's Health July 2021, 51 (5) 16;
Reddit logo Twitter logo Facebook logo Mendeley logo
Tweet Widget Facebook Like LinkedIn logo

Jump to section

  • Top

More in this TOC Section

  • Climate change experts: ‘It is vital to reduce emissions now’
  • Globe In Brief
  • Accountability needed to end rights violations during wars
Show more Globe

Subjects

  • Infectious Disease
  • Immunization
  • Child Health

Popular features

  • Healthy You
  • Special sections
  • Q&As
  • Quiz
  • Podcasts

FAQs

  • Advertising
  • Subscriptions
  • For APHA members
  • Submissions
  • Change of address

APHA

  • Join APHA
  • Annual Meeting
  • NPHW
  • AJPH
  • Get Ready
  • Contact APHA
  • Privacy policy

© 2023 The Nation's Health

Powered by HighWire